The toxicity of selected pharmaceuticals to the aquatic plant Lemna minor

Fresenius Environmental Bulletin

Volumn 16, Issue 5, 2007, Pages 524-531

  Kaza, Michał ^a   Nałȩcz Jawecki, Grzegorz ^a   Sawicki, Józef ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

Lemna minor; Nervous system drugs; Pharmaceuticals; Photodegradation; Phytotoxicity; Thioridazine

Indexed keywords

ANGIOSPERM; AQUATIC PLANT; CONCENTRATION (COMPOSITION); DRUG; PHOTODEGRADATION; PHYTOTOXICITY; POLLUTION EXPOSURE; TOXIC SUBSTANCE;

ANIMALIA; EQUUS ASINUS; LEMNA; LEMNA MINOR; TRACHEOPHYTA;

EID: 34249330328     PISSN: 10184619     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Halling-Sorensen B., Nielsen S.N., Lanzky P.F., Ingerslev F., Holten-Lützhoft H.C. and Jorgensen S.E. (1998) Occurrence, fate and effects of pharmaceutical substances in the environment - a review. Chemosphere 36, 357-393.
2. Dietrich D.R., Webb S.F. and Petry T. (2002) Hot spot pollutants: Pharmaceuticals in the environment. Toxicol Lett 131, 1-3.
3. Jorgensen S.E. and Halling-Sorensen B. (2000) Drugs in the environment. Chemosphere 40, 691-699.
4. Kümmerer K. (2001) Drugs in the environment: emission of drugs, diagnostic aids and disinfectants into wastewater by hospitals in relation to other sources - a review. Chemosphere 45, 957-969.
5. Boreen A.L., Arnold W.A. and McNeill K. (2003) Photodegradation of pharmaceuticals in the aquatic environment: A review. Aquat Sci 65, 320-341.
6. Ternes T.A. (1998) Occurrence of drugs in German sewage treatment plants and rivers. Water Res 32, 3245-3260.
7. Zuccato E., Bagnati R., Fioretti F., Natangelo M., Calmari D. and Fanelli R. (2001) Environmental loads and detection of pharmaceuticals in Italy. In: Kümmerer, K. (ed) Pharmaceuticals in the environment. Springer-Verlag, Berlin, 19-28.
8. Zwiener C., Gremm T.J. and Frimmel F.H. (2001) Pharmaceuticals residues in the aquatic environment and their significance for drinking water production. In: Kümmerer, K. (ed) Pharmaceuticals in the environment. Springer-Verlag, Berlin, 81-90.
9. Webb S.R. (2001) A data-based perspective on the environmental risk assessment of human pharmaceuticals. In: Kümmerer, K. (ed) Pharmaceuticals in the environment. Springer-Verlag, Berlin, 175-219.
10. Heberer T. (2002) Occurrence, fate and removal of pharmaceutical residues in the aquatic environment: A review of recent research data. Toxicol Lett 131, 5-17.
11. Kolpin D.W., Furlong E.T., Meyer M.T., Thuman B.M., Zaug S.D. and Barber L.B. (2002) Pharmaceuticals, hormones and other organic wastewater contaminants in US streams 1999-2000: A national reconnaissance. Envir Sci Technol 36, 1202-1211.
12. Metcalfe D.D., Koenig B.G., Bennie D.T., Servos M., Ternes E.A. and Hirsch R. (2003) Occurrence of neutral and acidic drugs in the effluents of Canadian sewage treatment plants. Environ Toxicol Chem 22, 2872-2880.
13. Cleuvers M. (2003) Aquatic ecotoxicity of pharmaceuticals including the assessment of combination effects. Toxicol Lett 142, 185-194.
14. Nałȩcz-Jawecki G. and Sawicki J. (2003) The toxicity of selected pharmaceuticals to the protozoa Spirostomum ambiguum and Tetrahymena termophila. Fresenius Environ Bull 12, 840-843.
15. Cleuvers M. (2005) Initial risk assessment for three beta-blockers found in the aquatic environment. Chemosphere 59, 199-205.
16. Sanderson H., Brain R.A., Johnson D.J., Wilson C.J. and Solomon K.R. (2004) Toxicity classification and evaluation of four pharmaceuticals classes: antibiotics, antineoplastics, cardiovascular and sex hormones. Toxicology 203, 27-40.
17. Nałȩcz-Jawecki G. and Persoone G. (2006) Toxicity of selected pharmaceuticals to the anostracan crustacean Thamnocephalus platyurus. Comparison of sublethal and lethal effect levels with the 1h Rapidtoxkit and the 24h Thamnotoxkit Microbiotests. Environ Sci & Pollut Res 13, 2-8.
18. Lewis M.A. (1995) Use of fresh water plants for phytotoxicity testing - a review. Environ Poll 87, 319-336.
19. Isidori M., Lavorgna M., Nardelli A., Parrella A., Previtera L. and Rubino M. (2005) Ecotoxicity of naproxen and its phototransformation products. Sci Total Environ 348, 93-101.
20. DellaGreca M., Fiorentino A., Isidori M., Lavorgna M, Previtera L., Rubino M. and Temussi F. (2004) Toxicity of prednisolone, dexamethasone and thei photochemical derivatives on aquatic organisms. Chemosphere 54, 629-637.
21. Cleuvers M. (2004) Mixture toxicity of the anti-inflammatory drugs diclofenac, ibuprofen, naproxen and acetylsalicylic acid. Ecotoxicol Environ Safe 59, 309-315.
22. Pomati F., Netting A.G., Calamari D. and Neilan B.A. (2004) Effects of erythromycin, tetracycline and ibuprofen on the growth of Synechocystis sp. and Lemna minor. Aquatic Toxicol 67, 387-396.
23. Pro J., Ortiz J.A., Boleas S., Fernandez C., Carbonell G. and Tarazona J.V. (2003) Effect assessment of antimicrobial pharmaceuticals on the aquatic plant Lemna minor. Bull Environ Contam Toxicol 70, 290-295.
24. ISO/WD 20079 (2001) Water quality - Duckweed growth inhibition, determination of the toxic effect of water constituents and wastewater to duckweed (Lemna minor). Draft document.
25. Commision of the European Communities (1996) Technical guidance document in support of commission directive 93/67/EEC on risk assessment for new notified substances and commission regulation (EC) No 1488/94 on risk assessment for existing substances. Part II; Environmental Risk Assessment. Office for official publications of the European Communities, Luxembourg.
26. Brooks B.W., Foran C.M., Richards S.M., Weston J., Turner P.K., Stanley J.K., Solomon K.R., Slattery M. and La Point T.W. (2003) Aquatic ecotoxicology of fluoxetine. Toxicol Lett 142, 169-183.
27. nd ed. Springer-Verlag.
28. Fent K., Weston A.A. and Caminada D. (2006) Ecotixicology of human pharmaceuticals. Aquatic Toxicol 76, 122-159.
29. Ferrari B., Paxeus N., Lo Giudice R., Pollio A. and Garric J. (2003) Ecotoxicological impact of pharmaceuticals found in treated wastewaters: study of carbamazepine, clofibric acid and diclofenac. Ecotoxicol Environ Safe 55, 359-370.
30. Thaker (2005) Pharmaceutical data elude researches. Environ Sci Technol 139, 193A-194A.
31. Fong P.P. (1998) Zebra mussel spawning is induced in low concentrations of putative serotonin reuptake inhibitors. Biol Bull 194, 143-149.
32. Flaherty C.M., Kashian D.R. and Dodson S.I. (2001) Ecological impacts of pharmaceuticals on zooplankton:effects of three medications on Dapnia magna. In: Proceedings of the annual meeting of the society of environmental toxicology and chemistry, Baltimore.
33. Henry T.B., Kwon J.W., Armbrust K.I. and Black M.C. (2004) Acute and chronic toxicity of five selective serotonin reuptake inhibitors in Ceriodaphnia dubia. Environ Toxicol Chem 23, 2229-2233.
34. Buser H.R., Poiger T. and Müller M.D. (1998) Occurrence and fate of the pharmaceutical drug diclofenac in surface waters: rapid photodegradation in a lake. Environ Sci Technol 32, 3449-3456.
35. Agüera A. (2005) Application of time-of-flight mass spectrometry to the analysis of phototransformation products of diclofenac in water under natural sunlight. J Mass Specrom 40, 908-915.
36. Andreozzi R., Raffaele M. and Nicklas P. (2003) Pharmaceuticals in STP effluents and their solar photodegradation in aquatic environment. Chemosphere 50, 1319-1330.
37. Schmitt-Jansen M., Adler N., Bartels P. and Altenburger R. (2006) Enhanced phytotoxicity by phototransformiation products of Diclofenac? Poster on SETAC Annual Meeting, The Hague.